Paul Alfred Gurbel MD FACC, FSCAI,FAHA
Adult Congenital Heart Disease, Interventional Cardiology
Professor of Medicine, Johns Hopkins University Adjunct Professor of Medicine, Duke University
Join to view full profile
2401 W. Belvedere AvenueSinai Center for Thrombosis Research and Drug Development Schapiro Bldg, South Tower, 2nd FloorBaltimore, MD 21215
Phone+1 410-367-2590
Dr. Gurbel is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Paul Gurbel is a cardiologist based in Baltimore, MD, specializing in interventional cardiology. He completed his medical education at the University of Maryland School of Medicine and advanced training through fellowships at Johns Hopkins University and Duke University Hospital. Dr. Gurbel has held leadership positions and cardiology roles at LifeBridge Health, Sinai Cardiovascular Faculty, Inova Fairfax Medical Campus, and the University of Maryland Medical System. He is experienced in general cardiology, interventional cardiology, and critical care. His research contributions include numerous publications and leadership in clinical trials as a principal investigator. He has received multiple honors, including the Distinguished Alumnus Award from Johns Hopkins University and Doctor Honoris Causa from Nicolaus Copernicus University.
Education & Training
Duke University HospitalFellowship, Cardiovascular Disease, 1987 - 1990- Duke University HospitalChief Residency, Internal Medicine, 1988 - 1989
Johns Hopkins UniversityFellowship, Pulmonary Disease and Critical Care Medicine, 1986 - 1987- Duke University HospitalResidency, Internal Medicine, 1983 - 1986
University of Maryland School of MedicineClass of 1983
Certifications & Licensure
MD State Medical License 1986 - 2028
VA State Medical License 2015 - 2020
NC State Medical License 1987 - 1992
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Cardiovascular Disease
- American Board of Internal Medicine Interventional Cardiology
Awards, Honors, & Recognition
- Best Doctors in Baltimore Baltimore Magazine
- Fellow AHA AHA
- Best Doctors
Clinical Trials
- Peri-Procedural Myocardial Infarction, Platelet Reactivity, Thrombin Generation, and Clot Strength: Differential Effects of Eptifibatide + Bivalirudin Versus Bivalirudin
- Flavonoid Effect on Activation and Stimulation of Thrombocytes, hsCRP and Lipid Profile
- Thrombocyte Activity Reassessment and GEnoTyping for PCI(TARGET-PCI)
Publications & Presentations
PubMed
- Lipoprotein(a), Oxidized Phospholipids and Tensile Clot Strength Measured by Thromboelastography in Patients Undergoing Percutaneous Intervention.Paul A Gurbel, Udaya S Tantry, Kevin P Bliden, William W Ashley, Young Hoon Jeong
Arteriosclerosis, Thrombosis, and Vascular Biology. 2026-08-20 - State of the Art: Personalized Antiplatelet Therapy by Genotype and Platelet Function Testing.Paul A Gurbel, Young-Hoon Jeong, Eliano Navarese, Jacek Kubica, Bogumil Ramotowski
Catheterization and Cardiovascular Interventions. 2026-08-05 - Clopidogrel Vs Aspirin Monotherapy for Secondary Prevention After Percutaneous Coronary Intervention: A Nationwide Cohort Study.Jun Hwan Cho, Seng Chan You, Hoseob Kim, Mina Kim, Jinhwan Jo
JACC. Asia. 2026-08-01
Abstracts/Posters
- [Board 554] Comparing Carvedilol With Metoprolol Succinate For All-Cause Mortality in Patients With Heart Failure With Reduced Ejection Fraction: A Systematic Review a...Paul Gurbel, 2019 ACC Scientific Session & Expo, New Orleans, New Orleans, 3/18/2019
- [Board 047] Point-of-Care CYP2C19 Genotype Guided Antiplatelet Therapy in Cardiac Catheterization Laboratory and Clinical Outcomes After PCIPaul Gurbel, 2019 ACC Scientific Session & Expo, New Orleans, New Orleans, 3/17/2019
Press Mentions
Urgent Warning over Drug Taken by Millions – as AstraZeneca Accused of ‘Misreporting’ Safety DataJune 20th, 2025- Combined Atherectomy and Intravascular Lithotripsy in Calcified Coronary Lesions: A Meta-AnalysisFebruary 20th, 2025
- Sinai Center for Thrombosis Research and Drug DevelopmentJune 23rd, 2022
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
